Velislava Terzieva
Overview
Explore the profile of Velislava Terzieva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pasev M, Trifonova A, Velichkov A, Terzieva V
Int Immunopharmacol
. 2024 Apr;
133:112084.
PMID: 38621337
The 2019 coronavirus (COVID-19) pandemic raised many scientific and medical questions. Of interest are the duration and effectiveness of the humoral immune response, especially since part of the pandemic occurred...
2.
He R, Zheng X, Zhang J, Liu B, Wang Q, Wu Q, et al.
Signal Transduct Target Ther
. 2023 Oct;
8(1):393.
PMID: 37802996
Long-term humoral immunity to SARS-CoV-2 is essential for preventing reinfection. The production of neutralizing antibody (nAb) and B cell differentiation are tightly regulated by T follicular help (T) cells. However,...
3.
Trifonova A, Syarov A, Takov S, Angelov K, Vazharova R, Terzieva V
Infect Dis (Lond)
. 2023 Jul;
55(11):803-807.
PMID: 37493404
Background: The SARS-CoV-2 virus significantly changed our knowledge about coronaviruses. The interplay between SARS-CoV-2 and the human host, the infection ranges from asymptomatic to lethal, and differences in the degree...
4.
Velichkov A, Susurkova R, Muhtarova M, Guenova M, Charmeteau-De Muylder B, Cheynier R, et al.
J Reprod Immunol
. 2023 Jan;
155:103793.
PMID: 36603467
Unexplained infertility has a huge social impact and is a significant challenge for both clinicians and researchers. Previous studies have shown the involvement of multiple factors in infertility. Among these,...
5.
Peruhova M, Georgieva V, Yurukova N, Sekulovska M, Panayotova G, Mihova A, et al.
World J Transplant
. 2020 Sep;
10(5):138-146.
PMID: 32864359
Background: Although ABO-nonidentical and ABO-incompatible liver transplantation (LT) are other options for end-stage liver disease treatment, the development of antibodies against blood group antigens (anti-A/B antibodies) is still a challenge...
6.
Terzieva V, Mihova A, Altankova I, Velikova T, Donchev D, Uzunova J, et al.
Monoclon Antib Immunodiagn Immunother
. 2019 Jul;
38(4):137-144.
PMID: 31361582
Among multiple parameters, applied in the immunologic monitoring of transplantation, the levels of serum soluble CD30 (sCD30) and peripheral regulatory T cells (Tregs) are very promising. These are relatively new...
7.
Velichkov A, Susurkova R, Mihova A, Muhtarova M, Guenova M, Antonova I, et al.
Monoclon Antib Immunodiagn Immunother
. 2019 Jun;
38(3):114-119.
PMID: 31192779
The establishment of a relevant regulatory T cell (Treg) pool in the periphery is of importance to ensure immune homoeostasis. Finely tuned signaling pathways in Tregs control the immune response...
8.
Seghrouchni F, Contini S, Markova R, Drenska R, Sadki K, Baassi L, et al.
Tuberculosis (Edinb)
. 2009 May;
89(3):210-7.
PMID: 19447677
In vitro diagnosis of MTB-infection uses MTB-proteins coded for by genes of the region of differentiation 1 (RD1) of the MTB genome. This study wants to test if proteins preferentially...
9.
Terzieva V
Viral Immunol
. 2008 Aug;
21(3):285-91.
PMID: 18673076
Recently, it has been emphasized that chronic generalized immune activation is a leading event in the pathogenesis of HIV-1 infection. Supporting evidence comes from observations that in cases of lack...
10.
Marchetti G, Meroni L, Varchetta S, Terzieva V, Bandera A, Manganaro D, et al.
J Infect Dis
. 2002 Aug;
186(5):606-16.
PMID: 12195347
Twenty-two patients with CD4(+)cell counts <or=200 cells/microL after 12 months of stable highly active antiretroviral therapy (HAART; "immunologic nonresponders") were randomly assigned to receive subcutaneous low-dose prolonged intermittent interleukin (IL)-2...